<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">25624</article-id><article-id pub-id-type="doi">10.7554/eLife.25624</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Efficacy of β-lactam\β-lactamase inhibitor combination is linked to WhiB4 mediated changes in redox physiology of <italic>Mycobacterium tuberculosis</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="author-81410"><name><surname>MISHRA</surname><given-names>Saurabh</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81411"><name><surname>Shukla</surname><given-names>Prashant</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81412"><name><surname>Bhaskar</surname><given-names>Ashima</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81413"><name><surname>Anand</surname><given-names>Kushi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81414"><name><surname>Baloni</surname><given-names>Priyanka</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81415"><name><surname>Jha</surname><given-names>Rajiv Kumar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81416"><name><surname>Mohan</surname><given-names>Abhilash</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81424"><name><surname>Rajmani</surname><given-names>Raju S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42790"><name><surname>Nagaraja</surname><given-names>Valakunja</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81425"><name><surname>Chandra</surname><given-names>Nagasuma</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-80571"><name><surname>Singh</surname><given-names>Amit</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6761-1664</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Microbiology and Cell Biology</institution>, <institution>Indian Institute of Science</institution>, <addr-line><named-content content-type="city">Bangalore</named-content></addr-line>, <country>India</country></aff><aff id="aff2"><institution>National Institute of Immunology</institution>, <addr-line><named-content content-type="city">New Delhi</named-content></addr-line>, <country>India</country></aff><aff id="aff3"><institution content-type="dept">Department of Biochemistry</institution>, <institution>Indian Institute of Science</institution>, <addr-line><named-content content-type="city">Bangalore</named-content></addr-line>, <country>India</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-56267"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role>Reviewing editor</role><aff><institution>University of the Witwatersrand</institution>, <country>South Africa</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>asingh@mcbl.iisc.ernet.in</email> (AS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>26</day><month>05</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e25624</elocation-id><history><date date-type="received"><day>31</day><month>01</month><year>2017</year></date><date date-type="accepted"><day>24</day><month>05</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, MISHRA et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>MISHRA et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-25624-v1.pdf"/><abstract><p><italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>) expresses a broad-spectrum β-lactamase (BlaC) that mediates resistance to one of the highly effective antibacterials, β-lactams. Nonetheless, β-lactams showed mycobactericidal activity in combination with β-lactamase inhibitor, clavulanate (Clav). However, the mechanistic aspects of how <italic>Mtb</italic> responds to β-lactams such as Amoxicillin in combination with Clav (referred as Augmentin [AG]) are not clear. Here, we identified cytoplasmic redox potential and intracellular redox sensor, WhiB4, as key determinants of mycobacterial resistance against AG. Using computer-based, biochemical, redox-biosensor, and genetic strategies, we uncovered a functional linkage between specific determinants of β-lactam resistance (<italic>e.g.,</italic> β-lactamase) and redox potential in <italic>Mtb</italic>. We also describe the role of WhiB4 in coordinating the activity of β-lactamase in a redox-dependent manner to tolerate AG. Disruption of WhiB4 enhances AG tolerance, whereas overexpression potentiates AG activity against drug-resistant <italic>Mtb</italic>. Our findings suggest that AG can be exploited to diminish drug-resistance in <italic>Mtb</italic> through redox-based interventions. through redox-based interventions.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001407</institution-id><institution>Department of Biotechnology , Ministry of Science and Technology</institution></institution-wrap></funding-source><award-id>BT/PR5020/MED/29/1454/2012</award-id><principal-award-recipient><name><surname>Singh</surname><given-names>Amit</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>WT-DBT/500034-Z-09-Z</award-id><principal-award-recipient><name><surname>Singh</surname><given-names>Amit</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was carried out in strict accordance with the guidelines provided by the Committee for the Purpose of Control and Supervision on Experiments on Animals (CPCSEA), Government of India. The protocol was approved by the Committee on the Ethics of Animal Experiments of the International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India (Approval number: ICGEB/AH/2011/2/IMM-26). All efforts were made to minimize the suffering.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="datasets"><title>Major datasets</title><p/><p>The following datasets were generated:</p><p><related-object content-type="generated-dataset" id="dataro1" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE93091" source-id-type="uri"><collab>Mishra S</collab>, <collab>Singh A</collab>, <year>2017</year><x>,</x> <source>Transcriptomic analysis of Mtb H37Rv and MtbΔwhiB4 on treatment to 10X Augmentin (AG) i.e. combination of 100 µg/ml of Amoxicillin and 8 µg/ml of Clavulanate and lower Augmentin doses at 1X and 5X</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE93091">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE93091</ext-link><x>,</x> <comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE93091)</comment></related-object><related-object content-type="generated-dataset" id="dataro2" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73877" source-id-type="uri"><collab>Parikh P</collab>, <collab>Chawla M</collab>, <collab>Singh A</collab>, <year>2017</year><x>,</x> <source>Transcriptomic analysis of Mtb H37Rrv and MtbΔwhiB4 upon treatment with 0.25 mM CHP</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73877">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73877</ext-link><x>,</x> <comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE73877)</comment></related-object></p></sec><supplementary-material><ext-link xlink:href="elife-25624-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>